IMPORTANCE
The availability of three different hemolysin genotypes in the ST631 lineage provided a unique opportunity to employ genome comparisons to further our understanding of the processes underlying pathogen evolution. The fact that two different pathogenic clades arose in parallel from the same potentially benign lineage by independent VPaI acquisition is surprising considering the historically low prevalence of community members harboring VPaI in waters along the Northeast U.S. coast that could serve as the source of this material. This illustrates a possible predisposition of some lineages to not only acquire foreign DNA but also become human pathogens. Whereas the underlying cause for the expansion of V. parahaemolyticus lineages harboring VPaI␥ along the U.S. Atlantic coast and spread of this element to multiple lineages that underlies disease emergence is not known, this work underscores the need to define the environment factors that favor bacteria harboring VPaI in locations of emergent disease.
KEYWORDS emerging pathogen, genomics, HGT, pathogen evolution, pathogenicity islands, type III secretion systems, vibrio, whole-genome phylogeny, molecular epidemiology V ibrio parahaemolyticus is an emergent pathogen capable of causing human gastric infections when consumed, most often with contaminated shellfish (1, 2) . Some human-pathogenic V. parahaemolyticus variants evolve from diverse nonpathogenic communities through horizontal acquisition of Vibrio pathogenicity islands (VPaI) (3) (4) (5) . Enteropathogenic V. parahaemolyticus typically harbor islands with at least one of two types of horizontally acquired hemolysin genes (tdh and trh) that are routinely used for pathogen discrimination even though their role in disease appears modest (6) (7) (8) (9) (10) (11) . Most pathogenic V. parahaemolyticus isolates also carry accessory type 3 secretion systems (T3SS) that translocate effector proteins that contribute to host interaction (12) (13) (14) . Two evolutionarily divergent horizontally acquired accessory systems (T3SS2␣ and T3SS2␤) contribute to human disease and are genetically linked to hemolysin genes (two tdh genes with T3SS2␣, and trh with T3SS2␤) in contiguous but distinct islands (4, (15) (16) (17) . The first described tdh-harboring island (called by several different names including Vp-PAI [15] , VPaI-7 [4] , and tdhVPA [17] ) from an Asian pandemic strain called RIMD 2210366 is fairly well characterized (4, 5, 13, 18, 19) . In contrast, islands containing T3SS2␤ linked to trh and a urease (ure) cluster, which confers a useful diagnostic phenotype, (where similar islands are described by others as Vp-PAI TH3966 [16] or trhVPA [17, 20] ) have received only modest attention. Pathogenic variants harboring both tdh and trh are increasingly associated with disease in North America (21) (22) (23) (24) (25) (26) , and yet, to our knowledge, the exact configuration of hemolysin-associated VPaI in isolates that contain both tdh and trh has not yet been described (see also reference 20) . Thus, it is unclear how virulence loci and islands in these emergent pathogen lineages carrying both hemolysins evolved and spread.
The expanding populations of V. parahaemolyticus have increased infections even in temperate regions previously only rarely impacted by this pathogen and where most environmental isolates harbor no known virulence determinants (27) . A related complex of Asia-derived pandemic strains, most often identified as serotype O3:K6 and also known as sequence type 3 (ST3; based on allele combinations of seven housekeeping genes) causes the most disease globally (28) . An unrelated Pacific native lineage called ST36 (also described as serotype O4:K12) currently dominates infections in North America, including from the Northeast United States (21, 26, 29) . The introduction of ST36 into the Atlantic Ocean by an unknown route precipitated a series of outbreaks from Atlantic shellfish starting in 2012 (29, 30) . Prior to 2012, resident lineages contributed to low but increasing sporadic infection rates on the Northeast U.S. coast (https://www.cdc.gov/vibrio/surveillance.html, 2017; see also reference 21), with ST631 emerging as the major lineage that is endemic to nearshore areas of the Atlantic Ocean bordering North America (the northwest Atlantic Ocean) (31) . However, we previously identified a single ST631 isolate lacking hemolysins (21, 27) , suggesting this pathogen lineage may have recently evolved through VPaI acquisition.
The goal of our study was to understand the genetic events and changing population context for the evolution of the ST631 pathogenic lineage. We conducted whole and core genome phylogenetic analyses of 3 environmental and 39 clinical ST631 isolates, along with isolates from other emergent lineages from the region, which revealed two ST631 clades of common ancestry, from which human pathogens evolved in parallel. The single clade I clinical isolate acquired a recA gene insertion previously seen associated with Asian lineages and had a VPaI that is typical of isolates harboring trh in the absence of tdh. In contrast, isolates from the clonal ST631 clade II that dominates Atlantic-derived ST631 infections (31) had a related but distinct VPaI.
This VPaI contained a tdh gene inserted within, not next to, an existing ure-trh-T3SS2␤ island in close proximity to the ure cluster. Nearly all emergent resident and invasive lineages, including all three Pacific lineages (ST36, ST636, and ST43) contained islands that similarly had a tdh gene inserted within the VPaI in an identical location adjacent to the ure cluster providing a mechanism for simultaneous acquisition of both hemolysins with T3SS2␤.
RESULTS
Atlantic endemic ST631 and several invasive lineages harboring both the tdh and trh hemolysin genes are clinically prevalent in four reporting Northeast U.S. states. Ongoing analysis of clinical isolates revealed that even as the Pacific-derived ST36 lineage continued to dominate infections (50%), the endemic (autochthonous) ST631 lineage accounted for 14% of infections (Table 1) . Concurrently, a limited number (27) . Since 2012, hemolysin producers have been recovered more frequently and in the last 2 years their proportion has increased by up to an order of magnitude (comprising as much as 10%) in some regional shellfish-associated populations (data not shown).
A single clinical ST631 lineage isolate with an unusual recA allele harbors trh in the absence of tdh. Employing ST631-specific marker-based assays (see Materials and Methods), we identified two additional 2015 environmental isolates (one from New Hampshire and one from Massachusetts) and one additional 2011 local-source clinical isolate (MAVP-R) (21) with a hemolysin profile (trh ϩ without tdh) that is atypical of the ST631 lineage (Table 1) . Although analysis of the seven-housekeeping-gene allele combination confirmed that the environmental isolates were indeed ST631, MAVP-R was not ST631 based on only one locus: recA. Examination of the recA locus of MAVP-R uncovered a large insertion within the ancestral ST631 recA gene (allele recA21 [https:// pubmlst.org/vparahaemolyticus/]) incorporating an intact but different recA gene into the locus (allele recA107 [33] ) and fragmenting the ancestral gene (Fig. 1) . The insertion in the ancestral recA gene in MAVP-R is identical to one observed in the recA locus of two Hong Kong isolates (isolates S130 and S134) and similar to the one in isolate 090-96 (ST189a) isolated in Peru but believed to have originated in Asia (33) .
ST631 forms two divergent clades. The existence of three different hemolysin profiles (Table 1 ) among all available ST631 draft genomes suggested there could be more than one ST631 lineage. Therefore, we evaluated whole-genome maximumlikelihood (ML) phylogenies of select ST631 isolates and all other lineages causing two or more infections reported in four states in Northeast United States to evaluate whether there was more than one ST631 lineage (Table 1 and Fig. 2 ). The phylogenetic tree showed that ST631 isolates, regardless of their hemolysin genotype, clustered together, but they formed two distinct clades, a finding indicative of common ancestry (Fig. 2) . Clade I harbored either trh or no hemolysins and consisted of all three environmental isolates which were from Massachusetts and New Hampshire, and the single clinical isolate MAVP-R, whereas clade II consisted of all other isolates, all of which harbor both hemolysins. The two distinct ST631 clades shared 85% of their DNA in common and displayed polymorphisms in Յ12% of the shared DNA content. The most closely related sister lineage to ST631 was formed by trh-harboring ST1127 isolates that have been exclusively reported from clinical sources in the Northeast United States (21) .
We next evaluated the relationships of all available ST631 isolate genomes at NCBI and sequenced by us (Table 2 ) using a custom core genome multilocus sequence typing (cgMLST) method as previously described (31) . Minimum spanning trees built from core genome loci from 42 ST631 isolates indicated that only 390 loci varied between the most closely related isolate of clade I (MAVP-L) and clade II (G6928)
FIG 1
Schematic of a horizontally acquired insertion in the recA-encoding region of MAVP-R. Sequences of the recA gene and flanking region from MAVP-Q (reference ST631 genome), MAVP-R, Asia-derived isolates S130/S134, and Peru-derived isolate 090-96 were extracted and aligned. ORFs designated by arrows and illustrated by representative colors highlight homologous and unique genes. The percent similarity between homologs is illustrated by gray bars.
FIG 2 Phylogenetic relationships of V. parahaemolyticus lineages and identification of distinct ST631
clades. An ML phylogeny of representative V. parahaemolyticus genomes of clinical isolates causing two or more infections was built on whole-genome SNPs identified by reference-free comparisons, as described in Materials and Methods. The branch length represents the number of nucleotide substitutions per site. Numbers at the nodes represent percent bootstrap support where unlabeled nodes had bootstraps of Ͻ70%.
Parallel Evolution of Vibrio parahaemolyticus ST631
Applied and Environmental Microbiology (Fig. 3) . The most distantly related isolates within clade I (G149 and MAVP-R) exhibited 80 core genome locus differences, whereas clade II is clonal with only 51 variant loci between the most divergent isolates: clinical isolate 09-4436 and environmental isolate S487-4, both reported from Prince Edward Island, Canada ( Fig. 3 ) (31) . Each ST631 clade independently acquired a distinct pathogenicity island positioned on different chromosomes. Given the variation in ST631, comparisons between these isolates could not only elucidate the events that led to the evolution of two pathogenic clades but also address unresolved questions about the unique configurations and contents of pathogenicity islands in western Atlantic Ocean emergent lineages. The physical proximity of tdh with the ure cluster and trh, and the cooccurrence of tdh with T3SS2␤ reported in many tdh ϩ trh ϩ clinical isolates, suggested tdh could be located within or next to the same pathogenicity island harboring trh in at least some lineages as was previously suggested (20, 24, 34) . To identify the location and determine the architecture of the pathogenicity elements harboring hemolysin genes, we generated high-quality annotated genomes for the clade I ST631 isolate MAVP-R and clade II ST631 isolate MAVP-Q (both reported in 2011 from Massachusetts) employing PacBio sequencing. The pathogenicity island regions in these isolates genomes were extracted and aligned, and the contents were compared with pathogenicity islands harboring two tdh genes (previously called Vp-PAI [15] , VPaI-7 [4] , and tdhVPA [17] ) from RIMD 2210366 and Vp-PAI TH3996 (16; also called trhVPI [17] ) harboring trh (see Table S1 in the supplemental material). This comparison revealed that MAVP-R harbored a pathogenicity island typical of trh-containing isolates that includes a linked ure cluster and T3SS2␤ that is orthologous, with the exception of a few unique regions, with Vp-PAI TH3996 (16) (see Table S1 in the supplemental material and Fig. 4 ). Because the lack of convention in uniformly naming syntenic islands that distinguish them from distinctive and yet functionally analogous islands can impede communication, we will consistently reference the same island by a common descriptive name regardless of isolate lineage. We refer to islands sharing the same general configuration to that in MAVP-R by the name VPaI␤ and refer to tdh-containing islands similar to that described in strain RIMD 2210366 by the name VPaI␣, regardless of bacterial isolate background. We adopted this simplified nomenclature in reference to the version of the key virulence determinant carried in the islands (T3SS2␣ and T3SS2␤) in the two already-described island types. This scheme importantly accommodates naming of additional uniquely configured islands as they are identified. As noted previously (16, 17, 20) , VPaI␤ is dissimilar to VPaI␣ in most gene content with ϳ78 open reading frames (ORFs) unique to VPaI␤ (where the number of identified ORFs used for comparison can differ slightly depending on which annotation program is applied) (see Table S1 in the supplemental material and Fig. 4 ). Even so, VPaI␤ had many homologous genes of varying sequence identity (n ϭ ϳ38 ORFs, excluding tdh homology with trh) compared to VPaI␣ (Table S1 and Fig. 4) (4, 5, 16 ). Identification of some homologs required that we relax matching to 50%, such as for the divergent, but homologous T3SS2␣ and T3SS2␤ genes encoding the apparatus, chaperones, and some shared effectors (see Table S1 in the supplemental material). No homolog of the T3SS2␣ effector gene vopZ was identified, but a single ORF whose deduced protein sequence bears only 27% identity with VopZ is located in its place ( Fig. 2 and Table S1 in the supplemental material). VPaI␤ from strain TH3996 and VPaI␣ from pandemic strain RIMD 2210633 are inserted in an identical location in chromosome II adjacent to an acyl coenzyme A (acyl-CoA) hydrolase-encoding gene. In contrast, the VPaI␤s in MAVP-R, ST1127 isolate MAVP-25, and Asia-derived AQ4037 are in chromosome I, in each case in the same insertion location identified for strain AQ4037 (17) .
MAVP-Q contained both tdh and trh within the same contiguous unique VPaI (here called VPaI␥) that shared features with both VPaI␣ and VPaI␤ ( Fig. 4 ; see also Table S1 in the supplemental material). Specifically, VPaI␥ had a core that with few exceptions was orthologous in content and syntenous with VPaI␤ from MAVP-R (Fig. 4) . VPaI␥ displays high conservation with VPaI␣ near its 3= end, as has been described in other draft tdh ϩ trh ϩ harboring genomes (20) , as well as in the VPaI␤ of strain TH3996, although the presence of this element may not be typical of VPaI␤ (e.g., it is absent in the islands from AQ4037 [17] , MAVP-R, and MAVP-25). The VPaI␥ also contained a tdh gene homologous to tdh2 (also called tdhA) from VPaI␣ (98.6%) near its 5= end but not at the 5= terminus of the island (Fig. 4) . Rather, the DNA flanking both sides of the tdh gene in VPaI␥ was conserved in VPaI␤ of MAVP-R and absent from VPaI␣ (Fig. 4) . Analysis of 300 genomes of V. parahaemolyticus (representing a minimum of 28 distinct sequence types) of sufficient quality for analysis confirmed that the module of four hypothetical proteins preceding the tdh2 homolog was present only in trh-harboring genomes but not in genomes harboring tdh in the absence of trh (i.e., VPaI␣-containing genomes), providing evidence that the tdh gene was acquired horizontally by insertion into, not next to, an existing VPaI␤, perhaps through activity of the adjacent trans-
FIG 4
Comparisons of the pathogenicity islands containing hemolysins and T3SS2. Sequences of VPaI were extracted from select genomes and aligned. VPaI␣ was derived from ST3 strain RIMD2210633, VPaI␥ was derived from ST631 clade II isolate MAVP-Q, and VPaI␤ was derived from ST631 clade I isolate MAVP-R. ORFs are depicted in defined colors, and similarities (Ն75%) among ORFs are illustrated in gray blocks. Homologs between VPaI␣ and VPaI␤/␥ (50 to Ͼ75% identity) are named and listed in Table S1 in the supplemental material.
posase gene (11) (see Table S2 and Fig. S1 in the supplemental material; also, data not shown). As with VPaI␣ from RIMD 2210633 and VPaI␤ of TH3996, VPaI␥ of clade II ST631 is located in a conserved location of chromosome II, adjacent to an acyl-CoA hydrolaseencoding gene.
The final environmental ST631 clade I isolate that lacked hemolysins, G149, had no VPaI␣, -␤, or -␥ elements in its genome. Close examination of the DNA corresponding to the VPaI insertion sites in either chromosome revealed no remnants of these islands in either chromosomal location, indicating this isolate likely never acquired a VPaI␣, -␤, or -␥ (see Fig. S2 in the supplemental material; also, data not shown). Because clade I isolate G149 lacked these islands, this could be the ancestral state of the ST631 lineage (21) .
Most clinically prevalent isolates from the Northeast United States harbor similar contiguous pathogenicity islands containing tdh inserted in the same island location. We next sought to determine whether isolates from other lineages likely residing within the mixed population with ST631 in nearshore areas of the Northeast United States harbored islands with structures similar to VPaI␥ that contain both hemolysin genes. Assembly of short-read sequences into contigs that cover the full length of VPaI, which is necessary for comparative analysis of entire island configuration, was impeded by the fact that homologous transposase genes and other sequences were repeated multiple times throughout the island. Therefore, we determined whether other lineages harboring both hemolysin genes harbor tdh in the same island location, between the conserved VPaI␤/␥ module of four hypothetical proteinencoding genes (to the left or 5= of tdh) and the ure cluster (to the right or 3= of tdh) (Fig. 4) by combining bioinformatics analysis of sequenced genomes with amplicon assays (see Fig. S1 in the supplemental material). First, we analyzed assembled draft genomes for tdh cooccurrence and proximity with the four adjacent hypothetical protein-encoding genes that are absent in VPaI␣ but present in VPaI␤/␥ (see Materials and Methods). Every emergent pathogenic lineage of the Northeast United States (Table 1) harboring both tdh and trh carried homologous DNA corresponding to all four hypothetical proteins adjacent to the tdh gene in a contiguous segment (see Table S2 in the supplemental material). To determine whether tdh was also adjacent to the ure cluster in these same isolates, we next designed specific flanking primers and amplified the unique juncture between the tdh-containing transposon-associated module and the ure cluster for all clinical isolates harboring both tdh and trh (see Materials and Methods; see also Fig. S1 in the supplemental material) . The results were congruent with our bioinformatics assessment (see Table S2 in the supplemental material) and demonstrated that isolates from all emergent pathogenic lineages harboring both hemolysins have tdh inserted in close proximity to an ure cluster in a configuration similar to VPaI␥ from MAVP-Q (Fig. 5 and Table 1 ). This confirmed that these isolates harboring both hemolysins harbor tdh within, and not next to, the same VPaI, thereby facilitating simultaneous acquisition of both hemolysin genes.
DISCUSSION
Even preceding the increased illnesses from Pacific-invasive lineages, two different clades of the predominant endemic Atlantic lineage of pathogenic V. parahaemolyticus, ST631 (31) evolved and contributed to a rise in sporadic illnesses in four reporting Northeast U.S. states (Table 1 and Fig. 2 and 3 ). Several lines of evidence support the interpretation of parallel pathogen evolution. The two lineages exhibit differences in both clinical and environmental prevalence, suggesting the pathogenic variants of each clade have not evolved the same degree of virulence (Table 1) . Pathogenic members in each lineage also acquired different pathogenicity islands with different hemolysin gene contents (Fig. 2 and 3) . Although it was a formal possibility that ST631 clade II evolved from clade I by independent horizontal acquisition of tdh into its existing VPaI␤, it is notable that other resident and even invasive lineages now in the Atlantic harbor VPaI␥ with tdh inserted into the same location of the island, suggesting a common evolutionary origin of this hybrid-type island (Fig. 4 and see Fig. S1 in the supplemental material). Finally, each of the two clades harbor VPaI insertions on different chromosomes: the less clinically prevalent ST631 clade I contains three isolates that harbor VPaI␤ in chromosome I (Fig. 3) and a single environmental isolate lacking any island (Table 1; Given that several other resident lineages harbor similar ␤-and ␥-type VPaI, pathogens in each clade could have acquired their islands from the reservoir of resident bacteria already circulating in the Atlantic even before the presumed arrival of invasive Pacific lineages. Several well-documented members of the Gulf of Mexico V. parahaemolyticus population (35) (36) (37) may also have expanded their range through movement of ocean currents and could be the source for these VPaI (Table 1 and Fig. 5 ). However, historically, hemolysin producers are extremely rare in nearshore areas of the Atlantic U.S. coast (25) and represented only about ϳ1% of isolates in an estuary of New Hampshire as of a decade ago (27) , limiting the potential for interacting partners or sources for acquired VPaI. Given this historical context, it is remarkable that two different clades from the same lineage independently acquired different VPaI, which for clade II ST631 occurred prior to 2007, well before the recent shift in abundance of hemolysin producers.
The parallel evolution of two different lineages through lateral DNA acquisition alludes to the possibility that as-yet-undefined attributes may increase the chances of acquisition or prime some bacterial lineages (such as ST631) to more readily acquire and maintain genetic material or become pathogenic upon island acquisition. Even though the ecological niche in which horizontal island acquisition took place is unknown, it is conceivable that cocolonization of hosts or substrates favorable to the growth of ST631 and hemolysin producers may have facilitated island movement. Certainly, an association of bacteria with specific marine substrates such as chitinous surfaces of plankton that also induce a natural state of competence could promote lateral transfer through close contact between the progenitors of the pathogenic subpopulation of each clade and island donors (3, 38, 39) . Alternatively, conjugative plasmids or transducing phage could have been the agents of island delivery. The finding that the only clinical clade I isolate, MAVP-R, also harbors a second horizontal insertion in its recA locus that matched one previously found in Asia-derived strains (33) indicates it acquired more than one segment of foreign DNA during its evolution as a pathogen (Fig. 1) , further illustrating that mechanisms that facilitate DNA transfer and acquisition may both have been at play. This also suggests that horizontal transfer of DNA from introduced bacteria not yet detected in the Atlantic could add to the genetic material available for pathogen evolution from Atlantic Ocean populations. More detailed molecular epidemiological, comparative genomics, and functional analyses necessary to assess the impact of introduced pathogens on resident Atlantic lineages are warranted given this evidence and the documented introduction of multiple Pacific-derived lineages in the region (Table 1) .
There has been some consideration of the roles of human virulence determinants in ecological fitness, but the natural context of pathogenic V. parahaemolyticus evolution is still unknown (40) (41) (42) . Whereas tdh and T3SS2␣ each may promote growth when bacteria are under predation, isolates that carry trh-containing islands (which likely also have T3SS2␤) do not derive similar benefits from their islands (43) . This is surprising considering the islands encode several homologous effectors (Fig. 4 and see Table S1 in the supplemental material) that do not have an established role in enteric disease, but they could alternatively or additionally mediate eukaryotic cell interactions with natural hosts, thereby promoting environmental fitness (13, 14) . However, these islands also lack a homologous gene for the VPaI␣ effector that is most closely associated with enteric disease: vopZ (11) (Fig. 4 and see Table S1 in the supplemental material). The general lack of knowledge of unique T3SS2␤ effectors and other gene function in these islands (Fig. 4 and Table S1 in the supplemental material), even with regard to enteric disease, limits comparative analysis with the well-studied and functionally defined VPaI␣, which could elucidate the bases for pathogen evolution. The higher clinical prevalence of clade II ST631 than clade I, which has also been recovered on more than one occasion from the environment (Table 1) , could indicate that VPaI␥ confers greater virulence potential than VPaI␤, perhaps owing to the presence of tdh, a known virulence factor (1, 7, 44) . However, the resident community members in both the Pacific and the Atlantic Ocean that harbor tdh and T3SS2␣ comparatively rarely cause human infections (21) (22) (23) . The unique environmental conditions that underlie pathogen success from northern latitudes that favors bacteria with VPaI␤ and VPaI␥, including two different ST631 lineages, suggest that the shared content of these islands could confer abilities that are distinct from VPaI␣ which could underlie the repeated acquisition and maintenance of these related islands by so many different lineages now present in nearshore areas of the Northeast United States.
MATERIALS AND METHODS
Bacterial isolates, media, and growth conditions. V. parahaemolyticus clinical isolates for this study were provided by cooperating public health laboratories in Massachusetts, New Hampshire, Maine, and Connecticut, whereas a select number of environmental isolates were enriched from estuarine substrates as described previously (21) . Detailed information about these isolates was described previously (31) and is listed in Table 2 . Isolates were routinely cultured in heart infusion media supplemented with NaCl and grown at 37°C as described previously (21) .
Whole-genome sequencing, assembly, annotation, and sequence type identification. Genomic DNA was extracted by using a Wizard Genomic DNA purification kit (Promega, Madison, WI) or by organic extraction (21) . The quality of genomic DNA was determined by spectrophotometric measurements by NanoDrop (Thermal Fisher, Waltham, MA). Libraries for DNA sequencing were prepared using a highthroughput Nextera DNA preparation protocol (45) using an optimal DNA concentration of 2 ng/l. Genomic DNA was sequenced using an Illumina HiSeq2500 device at the Hubbard Center for Genome Studies at the University of New Hampshire with a 150-bp paired-end library. De novo assembly was performed using the A5 pipeline (46) , and the assemblies were annotated with Prokka1.9 using the "genus" option and selecting "Vibrio" for the reference database (47) . The sequence types were subsequently determined using the SRST2 pipeline (48) . The sequence type of each genome was determined when using the V. parahaemolyticus database (https://pubmlst.org/vparahaemolyticus/). For most isolates where the combination of each allele was not found in the database representing novel sequence types, the genome was submitted for a new sequence type designation (https://pubmlst .org/vparahaemolyticus/).
Isolates MAVP-Q and MAVP-R were sequenced using the Pacific Biosciences RSII technology. Using between 3.7 and 5.3 g of DNA, the library preparation and sequencing was performed according to the manufacturer's instructions (Pacific Biosciences, Menlo Park, CA) and reflects the P5-C3 sequencing enzyme and chemistry for the MAVP-Q isolate and the P6-C4 configuration for MAVP-R. The mass of double-stranded DNA was determined by Qubit (Waltham, MA), and the sample was diluted to a final concentration of 33 g/l in a volume of 150 l of elution buffer (Qiagen, Germantown, MD). The DNA was sheared for 60 s at 4,500 rpm in a G-tube spin column (Covaris, Woburn, MA) that was subsequently flipped and respun for another 60 s at 4,500 rpm, resulting in an ϳ20,000-bp DNA verified using a DNA 12000 Bioanalyzer gel chip (Agilent, Santa Clara, CA). The sheared DNA isolate was then repurified using a 0.45ϫ AMPure XP purification step (Beckman Coulter, Indianapolis, IN). The DNA was repaired by incubation in DNA Damage Repair solution. The library was again purified using 0.45ϫ Ampure XP and SMRTbell adapters ligated to the ends of the DNA at 25°C overnight. The library was treated with an exonuclease cocktail (1.81 U/l Exo III 18 and 0.18 U/l Exo VII) at 37°C for 1 h to remove unligated DNA fragments. Two additional 0.45ϫ Ampure XP purifications steps were performed to remove Ͻ2,000-bp molecular weight DNA and organic contaminant.
Upon completion of library construction, samples were validated using an Agilent DNA 12000 gel chip. The isolate library was subjected to additional size selection to the range of 7,000 to 50,000 bp to remove any SMRTbells less than 5,000 bp using Sage Science Blue Pippin 0.75% agarose cassettes to maximize the SMRTbell sub-read length for optimal de novo assembly. Size selection was confirmed by Bio-Analysis, and the mass was quantified using the Qubit assay. Primer was then annealed to the library (80°C for 2.5 min, followed by decreasing the temperature by 0.1°/s to 25°C). The polymerase-template complex was then bound to the P5 or P6 enzyme using a 10:1 ratio of polymerase to SMRTbell at 0.5 nM for 4 h at 30°C and then held at 4°C until ready for MagBead loading prior to sequencing. The magnetic bead-loading step was conducted at 4°C for 60 min according to the manufacturer's guidelines. The MagBead-loaded, polymerase-bound, SMRTbell libraries were placed onto the RSII machine at a sequencing concentration of 110 to 150 pM and configured for a 180-min continuous sequencing run. Long-read assemblies were constructed using HGAP version 2.3.0 for de novo assembly generation. Further, hybrid assemblies were generated and error corrected with Illumina raw reads using Pilon v1.20 (49) .
Lineage-specific marker-based assays. To more rapidly identify ST631 isolates from clinical and environmental collections, we developed PCR-amplicon assays to unique gene content in ST631. Whole-genome comparisons were performed on MAVP-Q (a ST631 clinical isolate), G149 (a ST631 environmental isolate), MAVP-26 (ST36), RIMD2210633 (ST3), and AQ4037 (ST96) (see Fig. S3 in the supplemental material). A total of 26 distinct genomic regions, each Ͼ1 kb in size, were present in MAVP-Q but absent in other comparator genomes, including environmental ST631 that lacks hemolysins (G149) (see Fig. S3 in the supplemental material). Within a large genomic island ϳ37.6 kb in length with an integrase at one terminus and an overall lower GC content (40.6% compared to 45.8% for the genome), a single ORF homologous to restriction endonucleases (AB831_06355) that was restricted to clinical ST631 isolates in our collection and publicly available draft genomes (n ϭ 693; http:// www.ncbi.nlm.nih.gov/genome/691; 2017) was selected as a suitable amplicon target. The distribution of this locus was further analyzed using the BLAST algorithm by a query against the nucleotide collection, the nonredundant protein sequences, and against the genus Vibrio (taxid 662), excluding V. parahaemolyticus (taxid 691), using the default settings for BLASTn (50) . Similar approaches were applied to identify ST631 diagnostic loci inclusive of the single environmental isolate (G149), which identified a hypothetical protein encoding region (AB831_06535) (ST631env). Oligonucleotide primers were designed to amplify the diagnostic regions, including AB831_06355, using the primers ST631endF (5=-AG TTCATCAGGTAGAGAGTTAGAGGA-3=) and ST631endR (5=-TCTTCGTTACCATAGTATGAGCCA-3=), which produce an amplicon of ca. 494 bp, and AB831_06535, using the primers ST631envF (5=-TGGGCGTTAG GCTTTGC-3=) and ST631-envR (5=-GGGCTTCTACGACTTTCTGCT-3=), which produce an amplicon of 497 bp.
Amplification of diagnostic loci was evaluated in individual assays using genomic DNA from positive and negative controls: MAVP-Q and G149 (ST631), G4186 (ST34), G3578 (ST674), MAVP-M (ST1127), MAVP-26 (ST36), and G61 (ST1125). Amplification of specific sequence types were performed with Accustart enzyme mix on purified DNA. Cycling was performed with an initial denaturation at 94°C for 3 min, followed by 30 cycles of denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and amplification at 72°C for 30 s, with a final elongation at 72°C for 5 min. The primer pairs only produced amplicons from template DNA from ST631, and each was the expected size (data not shown; see Fig. S3 in the supplemental material). Amplicon assays were applied to 208 clinical isolates from Northeast U.S. states (Maine, New Hampshire, Massachusetts, and Connecticut) and 1,140 environmental isolates collected from 2015 to 2016 from New Hampshire and Massachusetts. These assays identified all known ST631 clinical isolates with 100% specificity and also identified an additional seven tdh ϩ trh ϩ clinical isolates (ST631end and ST631env positive) and two environmental isolates (ST631end negative and ST631env positive) from our archived collection. Each, with the exception of MAVP-R, was subsequently confirmed to be ST631 by seven-locus MLST (www.pubmlst.org).
Examination of recA allele and adjacent sequences. The PacBio sequenced genome of MAVP-R, contig 000001 (accession no. MPPP00000000) that contained the recA gene, was annotated using PROKKA1.9 (47) . The sequences of recA and its surrounding DNA were then compared to the contig-containing recA region from isolate S130 (AWIW01000000), S134 (AWIS01000000), 090-96 (JFFP01000036) (33) , and MAVP-Q (accession no. MDWT00000000). The map of recA region of the five isolates was illustrated using Easyfig (51) .
Core genome SNP determination and phylogenetic analysis. Whole-genome phylogenies were constructed with single-nucleotide polymorphisms (SNPs) identified from draft genomes using kSNP3 to produce aligned SNPs in FASTA format (52) . A maximum-likelihood (ML) tree was then built from the FASTA file using raxMLHPC with model GTRGAMMA and the "-f option," as well as 100 bootstraps (53) . Since there were no differences among the clade II ST631 isolates, we used a subset representing geographic and temporal span of isolation.
Minimum-spanning tree analysis was built based on core gene SNPs produced from a cluster analysis. The cluster analysis of ST631 was performed using a custom core genome multilocus sequence type (cgMLST) analysis using RidomSeqSphereϩsoftware v3.2.1 (Ridom GmbH, Münster, Germany) as previously described (31) . Briefly, the software first defines a cgMLST scheme using the target definer tool with default settings using the PacBio generated MAVP-Q genome as the reference. Then, five other V. parahaemolyticus genomes (BB22OP, CDC_K4557, FDA_R31, RIMD2210633, and UCM-V493) were used for comparison with the reference genome to establish the core and accessory genome genes. Genes that are repeated in more than one copy in any of the six genomes were removed from the analysis. Subsequently, a task template was created that contains both core and accessory genes. Each individual gene locus from MAVP-Q was assigned allele number 1. Each ST631 isolate genome assembly was then queried against the task template, where any locus that differed from the reference genome or any other queried genome was assigned a new allele number. The cgMLST performed a gene-by-gene analysis of all core genes (excluding accessory genes) and identified SNPs within different alleles to establish genetic distance calculations.
Configuration and distribution of VPaI. The VPaI sequence from the PacBio sequenced genomes of MAVP-Q and MAVP-R were identified by comparison with the published RIMD2210633 VPaI-7 (NC_004605 region between VPA1312 and VPA1395) and VPaI TH3996 (AB455531) (16) . Identification of the complete MAVP-Q VPaI␥ and genomic junctures in chromosome II was done by comparison to the same region of chromosome II in MAVP-R and G149 (which lack an island in this location) using Mauve (54) . In a reciprocal manner, the absence of an island in chromosome I in MAVP-Q and G149 was assessed by comparison with chromosome I of MAVP-R. MAVP-Q VPaI␥ (MF066646) and MAVP-R VPaI␤ (MF066647) were then extracted as a single contiguous sequence and annotated using Prokka 1.9. Gene content and order of the VPaI elements in MAVP-Q, MAVP-R, and RIMD2210633 were then illustrated by Easyfig (51) . Roary (55) was then used to determine homologs among VPaI based on each island's annotated sequences with identity set at 50%. Identification of the genome locations of VPaI␤ in ST1127 isolate MAVP-M (accession number GCA_001023155) and of VPaI␥ in AQ4037 (accession number GCA_000182365) (17) was also done using Mauve (54) .
To examine the distribution of the VPaI␥ in all publicly available draft genomes (https://www.ncbi .nlm.nih.gov/genome/genomes/691; 2016) and genomes from archived regional isolates, whole draft genome sequences were aligned to a 6,118-bp subsequence of the MAVP-Q VPaI with NASP version 1.0.2 (56) (https://pypi.python.org/pypi/nasp/1.0.2; 2017). This subsequence spanned the unique juncture of the four conserved hypothetical proteins (AB831_22090, AB831_22095, AB831_22100, and AB831_22105) with the adjacent inserted tdh (AB831_22110, ca. 2,549 bp upstream of ure cluster) (see Fig. S1 in the supplemental material). The percent coverage of the reference sequence was used to determine whether each genome harbored only the four hypothetical protein-encoding genes, only a tdh gene, or the entire module including the fusion of the four genes with tdh (see Fig. S1 and Table S2 in the supplemental material). The sequence type of each genome harboring the fused element characteristic of VPaI␥ was then determined using the SRST2 pipeline (48) . Where sequencing reads were not available as the input for SRST2, they were simulated from assemblies using an in-house Python script (https://github.com/kpdrees/fasta2reads).
A PCR amplification approach was developed and applied to survey the presence of tdh adjacent to the ure gene cluster. Primers were designed to anneal to conserved sequences at the 3= end of tdh (PIHybF8, 5=-GCCAACATGGATATAAATAAAAATGA-3=) and the 5= end of ureG (tdhUreGrev5, 5=-GACAAA GGTATGCTGCCAAAAGTG-3=) as determined by gene alignments, which when used together produced a 2,631-bp amplicon of the insertion juncture when used with MAVP-Q as a template (see Fig. S4 in the supplemental material). Amplification was performed on purified DNA with Accustart enzyme mix, with an initial denaturation at 94°C for 3 min, followed by 30 cycles of a denaturation at 94°C for 1 min, annealing at 61°C for 1 min, and amplification at 72°C for 2.5 min, with a final elongation at 72°C for 5 min. This amplification was performed in parallel with a diagnostic multiplex PCR amplification of tdh, trh, and tlh according to published methods (10, 57) to investigate the cooccurrence of VPaI␥ with both hemolysin-encoding genes in representative isolates of various clinically prevalent sequence types. Amplicons were visualized using a 1.2% agarose gel in Tris-acetate-EDTA (TAE) buffer (see Fig. S4 in the supplemental material) . Accession number(s). The accession numbers of the Pacific Biosciences sequenced genome for MAVP-Q are CP022473 for chromosome I and CP022472 for chromosome II, and those for MAVP-R are CP022552 for chromosome I, CP022553 for chromosome II, and CP022554 and CP022555 for the extrachromosomal (plasmid) sequence. Detailed information about all clade II ST631 strain genomes were described previously (31) , and these and the accession numbers for the remaining sequenced genomes are listed in Table 2 . The accession number of VPaI␤ from MAVP-R is MF066647, and the accession number of VPaI␥ from MAVP-Q is MF066646.
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